Spin-offs

Pfizer swings to quarterly loss because of Paxlovid, Covid vaccine write-offs

Pfizer reported a quarterly loss for the 0.33 quarter because the drugmaker recorded fees in large part associated with struggles for its Covid antiviral remedy Paxlovid and Covid vaccine.The effects come two

October 31, 2023

OpenAI

Pfizer beats profits estimates, hikes full-year outlook as drugmaker cuts prices

Kena Betancur | Corbis Information | Getty ImagesPfizer additionally hiked its income outlook to a variety of $59.5 billion to $62.5 billion, up from a prior income forecast of between $58.5 billion

July 30, 2024

Business

5 issues to grasp sooner than the inventory marketplace opens Friday

Media corporate Sinclair is having a look to promote just about 30% of its broadcast stations.Novavax signed a multibillion-dollar deal to commercialize its Covid vaccine.Apple apologized for an advert that drew grievance

May 10, 2024

Business

Pfizer tops earnings forecasts as declining Covid business outperforms expectations

Pfizer CEO Albert Bourla spoke at a press conference with European Commission President Ursula von der Leyen after visiting the production of the Pfizer-BioNtech COVID-19 vaccine at the Pfizer factory in Puurs,

January 30, 2024

Business

Spin-offs

Pfizer swings to quarterly loss because of Paxlovid, Covid vaccine write-offs

Pfizer beats profits estimates, hikes full-year outlook as drugmaker cuts prices

5 issues to grasp sooner than the inventory marketplace opens Friday

Pfizer tops earnings forecasts as declining Covid business outperforms expectations

Recent Posts

Categories

Suggestions

Spin-offs

Pfizer swings to quarterly loss because of Paxlovid, Covid vaccine write-offs

Pfizer beats profits estimates, hikes full-year outlook as drugmaker cuts prices

5 issues to grasp sooner than the inventory marketplace opens Friday

Pfizer tops earnings forecasts as declining Covid business outperforms expectations

Recent Posts

Categories